| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:51 UTC |
|---|
| Update Date | 2022-03-07 02:51:55 UTC |
|---|
| HMDB ID | HMDB0015269 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Sulfinpyrazone |
|---|
| Description | Sulfinpyrazone is only found in individuals that have used or taken this drug. It is a uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties. [PubChem]Sulfinpyrazone is an oral uricosuric agent (pyrazolone derivative) used to treat chronic or intermittent gouty arthritis. Sulfinpyrazone competitively inhibits the reabsorption of uric acid at the proximal convoluted tubule, thereby facilitating urinary excretion of uric acid and decreasing plasma urate concentrations. This is likely done through inhibition of the urate anion transporter (hURAT1) as well as the human organic anion transporter 4 (hOAT4). Sulfinpyrazone is not intended for the treatment of acute attacks because it lacks therapeutically useful analgesic and anti-inflammatory effects. Sulfinpyrazone and its sulfide metabolite possess COX inhibitory effects. Sulfinpyrazone has also been shown to be a UDP-glucuronsyltransferase inhibitor and a very potent CYP2C9 inhibitor. Sulfinpyrazone is also known to be a cystic fibrosis transmembrane conductance regulator (CFTR) inhibitor as well as an inhibitor of several multridrug resistance proteins (MRPs). |
|---|
| Structure | O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(N1C1=CC=CC=C1)C1=CC=CC=C1 InChI=1S/C23H20N2O3S/c26-22-21(16-17-29(28)20-14-8-3-9-15-20)23(27)25(19-12-6-2-7-13-19)24(22)18-10-4-1-5-11-18/h1-15,21H,16-17H2 |
|---|
| Synonyms | | Value | Source |
|---|
| 1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine | ChEBI | | 1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione | ChEBI | | 4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione | ChEBI | | Anturane | ChEBI | | Sulfoxyphenylpyrazolidine | ChEBI | | 1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulphinylethyl)pyrazolidine | Generator | | 1,2-Diphenyl-4-(2'-phenylsulphinethyl)-3,5-pyrazolidinedione | Generator | | 4-(2-Benzenesulphinylethyl)-1,2-diphenylpyrazolidine-3,5-dione | Generator | | Sulphoxyphenylpyrazolidine | Generator | | Sulphinpyrazone | Generator | | Diphenylpyrazone | HMDB | | Sulfinpyrazine | HMDB | | Sulfinpyrazon | HMDB | | Usaf ge-13 | HMDB | | Apo sulfinpyrazone | HMDB | | Nu pharm brand OF sulfinpyrazone | HMDB | | Nu sulfinpyrazone | HMDB | | Nu-pharm brand OF sulfinpyrazone | HMDB | | Nu-sulfinpyrazone | HMDB | | Sulfoxyphenylpyrazolidin | HMDB | | Anturan | HMDB | | Apo-sulfinpyrazone | HMDB | | Apotex brand OF sulfinpyrazone | HMDB | | Novartis brand OF sulfinpyrazone | HMDB |
|
|---|
| Chemical Formula | C23H20N2O3S |
|---|
| Average Molecular Weight | 404.482 |
|---|
| Monoisotopic Molecular Weight | 404.119463206 |
|---|
| IUPAC Name | 4-[2-(benzenesulfinyl)ethyl]-1,2-diphenylpyrazolidine-3,5-dione |
|---|
| Traditional Name | sulfinpyrazone |
|---|
| CAS Registry Number | 57-96-5 |
|---|
| SMILES | O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(N1C1=CC=CC=C1)C1=CC=CC=C1 |
|---|
| InChI Identifier | InChI=1S/C23H20N2O3S/c26-22-21(16-17-29(28)20-14-8-3-9-15-20)23(27)25(19-12-6-2-7-13-19)24(22)18-10-4-1-5-11-18/h1-15,21H,16-17H2 |
|---|
| InChI Key | MBGGBVCUIVRRBF-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as phenyl sulfoxides. These are organosulfur compounds containing a sulfoxide group substituted with a phenyl group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Phenyl sulfoxides |
|---|
| Direct Parent | Phenyl sulfoxides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Phenyl sulfoxide
- Pyrazolidinone
- 1,3-dicarbonyl compound
- Pyrazolidine
- Carboxylic acid hydrazide
- Sulfoxide
- Carboxylic acid derivative
- Azacycle
- Organoheterocyclic compound
- Sulfinyl compound
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 136 - 137 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.32 g/L | Not Available | | LogP | 2.4 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 7.51 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 15.5783 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.21 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 29.5 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 3108.9 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 366.4 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 197.5 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 191.5 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 217.8 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 629.4 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 554.9 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 65.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1362.9 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 563.2 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1652.3 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 386.2 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 410.6 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 208.8 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 97.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 11.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatized |
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Sulfinpyrazone GC-MS (Non-derivatized) - 70eV, Positive | splash10-004i-2962000000-94e8774039d3f0fcca8f | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Sulfinpyrazone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfinpyrazone LC-ESI-qTof , Positive-QTOF | splash10-004i-0002900000-472e293a011d716bb5a8 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfinpyrazone LC-ESI-qTof , Positive-QTOF | splash10-0550-2930000000-70abc4e49a7459cc1980 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfinpyrazone , positive-QTOF | splash10-0a6r-0591500000-4b27d64be1dee69f96e6 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfinpyrazone , positive-QTOF | splash10-004i-0002900000-472e293a011d716bb5a8 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfinpyrazone , positive-QTOF | splash10-0550-2930000000-70abc4e49a7459cc1980 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfinpyrazone 10V, Positive-QTOF | splash10-0a4i-0121900000-c9fce22e4f1bf8639c5f | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfinpyrazone 20V, Positive-QTOF | splash10-0aor-1982700000-265219a2340547ed8bbd | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfinpyrazone 40V, Positive-QTOF | splash10-0296-8980000000-1a7f9e1d8816c5ac0085 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfinpyrazone 10V, Negative-QTOF | splash10-0ufr-0611900000-4d4b16dafcc3e3c35c10 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfinpyrazone 20V, Negative-QTOF | splash10-004i-0900000000-6ced63b6018b3dc056eb | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfinpyrazone 40V, Negative-QTOF | splash10-004i-4900000000-d6a82452b72bf2aa7d3f | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfinpyrazone 10V, Positive-QTOF | splash10-0a4i-0010900000-c22c20a4b5ae18de64c5 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfinpyrazone 20V, Positive-QTOF | splash10-0a70-0091500000-79c6d2d2234f9c7c03c9 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfinpyrazone 40V, Positive-QTOF | splash10-01ri-3981000000-e2a706d32b4166dcf98f | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfinpyrazone 10V, Negative-QTOF | splash10-0fb9-0590700000-e4fb976008c18fe00f50 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfinpyrazone 20V, Negative-QTOF | splash10-004i-2951100000-ccd7d87659eeb242040e | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfinpyrazone 40V, Negative-QTOF | splash10-004l-8910000000-8627304c89a73101a237 | 2021-10-11 | Wishart Lab | View Spectrum |
|
|---|